{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:06:10Z","timestamp":1792789570753,"version":"4.5.0"},"reference-count":168,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid","award":["S1311011"],"award-info":[{"award-number":["S1311011"]}]},{"name":"JSPS KAKENHI","award":["17K16353"],"award-info":[{"award-number":["17K16353"]}]},{"name":"JSPS KAKENHI","award":["20K08680"],"award-info":[{"award-number":["20K08680"]}]},{"name":"JSPS KAKENHI","award":["18K07396"],"award-info":[{"award-number":["18K07396"]}]},{"name":"JSPS KAKENHI","award":["19K08756"],"award-info":[{"award-number":["19K08756"]}]},{"name":"JSPS KAKENHI","award":["16K08997"],"award-info":[{"award-number":["16K08997"]}]},{"name":"JSPS KAKENHI","award":["20H03568"],"award-info":[{"award-number":["20H03568"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Itch (or pruritus) was not previously recognized as a serious symptom of psoriasis. However, approximately 60\u201390% of psoriatic patients with pruritus have stated that it deteriorates their quality of life. Since conventional antipruritic therapies, such as antihistamines, only exert limited effects, the establishment of a treatment option for itch in psoriasis is urgently needed. Although a definitive drug is not currently available, various itch mediators are known to be involved in pruritus in psoriasis. In this review, we describe the clinical features of pruritus in psoriasis, classify a wide range of itch mediators into categories, such as the nervous, immune, endocrine, and vascular systems, and discuss the mechanisms by which these mediators induce or aggravate itch in the pathophysiology of psoriasis.<\/jats:p>","DOI":"10.3390\/ijms21218406","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T19:08:29Z","timestamp":1604948909000},"page":"8406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Molecular and Cellular Mechanisms of Itch in Psoriasis"],"prefix":"10.3390","volume":"21","author":[{"given":"Eriko","family":"Komiya","sequence":"first","affiliation":[{"name":"Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-1803","authenticated-orcid":false,"given":"Mitsutoshi","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"},{"name":"Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Kamata","sequence":"additional","affiliation":[{"name":"Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"},{"name":"Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Suga","sequence":"additional","affiliation":[{"name":"Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"},{"name":"Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takamori","sequence":"additional","affiliation":[{"name":"Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"},{"name":"Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"},{"name":"Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejp.768","article-title":"Pruritus in psoriasis: An update","volume":"20","author":"Szepietowski","year":"2016","journal-title":"Eur. J. Pain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.1988.tb03248.x","article-title":"Psoriasis","volume":"119","author":"Fry","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000446050","article-title":"Itch in Psoriasis Management","volume":"50","author":"Szepietowski","year":"2016","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jdv.15450","article-title":"Itch: An under-recognized problem in psoriasis","volume":"33","author":"Elewski","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40257-015-0169-x","article-title":"US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey","volume":"17","author":"Lebwohl","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1468-3083.2008.02591.x","article-title":"Patients\u2019 perspective of pruritus in chronic plaque psoriasis: A questionnaire-based study","volume":"22","author":"Amatya","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","article-title":"Neuropeptides and their receptors in psoriatic skin in relation to pruritus","volume":"156","author":"Chang","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_8","first-page":"122","article-title":"Pruritus in chronic plaque psoriasis: A questionnaire-based study of 230 Italian patients","volume":"22","author":"Stinco","year":"2014","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1365-2133.2004.06299.x","article-title":"Pruritus and psoriasis","volume":"151","author":"Szepietowski","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1365-2133.2000.03829.x","article-title":"The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis","volume":"143","author":"Yosipovitch","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaad.2017.02.002","article-title":"Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis","volume":"76","author":"Shahwan","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2133.2004.06093.x","article-title":"Prevalence of symptoms experienced by patients with different clinical types of psoriasis","volume":"151","author":"Sampogna","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","article-title":"Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","volume":"70","author":"Lebwohl","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5114\/pdia.2014.44010","article-title":"Apprehension of the disease by patients suffering from psoriasis","volume":"31","author":"Reich","year":"2014","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_15","first-page":"55","article-title":"Interplay of Itch and Psyche in Psoriasis: An Update","volume":"96","author":"Reich","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2340\/00015555-1246","article-title":"Assessment of pruritus intensity: Prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000073992","article-title":"Does Stress Influence Itching in Psoriatic Patients?","volume":"4","author":"Reich","year":"2003","journal-title":"Dermatol. Psychosom."},{"key":"ref_18","first-page":"221","article-title":"Itching in patients suffering from psoriasis","volume":"10","author":"Szepietowski","year":"2002","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5021\/ad.2014.26.6.727","article-title":"Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density","volume":"26","author":"Kim","year":"2014","journal-title":"Ann. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/09546634.2015.1034074","article-title":"Clinical symptoms and self-reported disease severity among patients with psoriasis\u2014Implications for psoriasis management","volume":"26","author":"Korman","year":"2015","journal-title":"J. Dermatol. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/09546634.2018.1528330","article-title":"Psoriasis-associated cutaneous pain: Etiology, assessment, impact, and management","volume":"30","author":"Pithadia","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaad.2013.09.030","article-title":"Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity","volume":"70","author":"Roblin","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clindermatol.2010.09.014","article-title":"The Koebner phenomenon","volume":"29","author":"Sagi","year":"2011","journal-title":"Clin. Dermatol."},{"key":"ref_24","unstructured":"Sanchez, D.P., and Sonthalia, S. (2020). Koebner Phenomenon. StatPearls, StatPearls Publishing LLC."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.celrep.2019.06.033","article-title":"Spinal Neuropeptide Y1 Receptor-Expressing Neurons Form an Essential Excitatory Pathway for Mechanical Itch","volume":"28","author":"Acton","year":"2019","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1523\/JNEUROSCI.3005-11.2011","article-title":"A role for nociceptive, myelinated nerve fibers in itch sensation","volume":"31","author":"Ringkamp","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-neuro-083019-024537","article-title":"Neural Mechanisms of Itch","volume":"43","author":"Lay","year":"2020","journal-title":"Annu Rev. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"adv00024","DOI":"10.2340\/00015555-3344","article-title":"Mechanisms and Management of Itch in Dry Skin","volume":"100","author":"Moniaga","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1346-8138.12317","article-title":"Itch and nerve fibers with special reference to atopic dermatitis: Therapeutic implications","volume":"41","author":"Tominaga","year":"2014","journal-title":"J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/exd.14029","article-title":"Addiction and the itch-scratch cycle. What do they have in common?","volume":"28","author":"Ishiuji","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_32","first-page":"457","article-title":"Antihistamines in the treatment of pruritus in psoriasis","volume":"34","author":"Szepietowski","year":"2017","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CCID.S4465","article-title":"Itch in psoriasis: Epidemiology, clinical aspects and treatment options","volume":"2","author":"Prignano","year":"2009","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079211","article-title":"Histamine, Substance P and Calcitonin Gene-Related Peptide Plasma Concentration and Pruritus in Patients Suffering from Psoriasis","volume":"5","author":"Szepietowski","year":"2004","journal-title":"Dermatol. Psychosom."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1365-2133.2003.05586.x","article-title":"Pruritogenic mediators in psoriasis vulgaris: Comparative evaluation of itch-associated cutaneous factors","volume":"149","author":"Nakamura","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1365-2133.2008.08515.x","article-title":"CD26\/dipeptidyl-peptidase IV in psoriatic skin: Upregulation and topographical changes","volume":"158","author":"Seyger","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12515092","article-title":"Flare and itch induced by substance P in human skin","volume":"71","author":"Pernow","year":"1978","journal-title":"J. Investig. Dermatol."},{"key":"ref_38","first-page":"1140","article-title":"Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice","volume":"286","author":"Andoh","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuron.2013.01.030","article-title":"Peptidergic CGRP\u03b1 primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold","volume":"78","author":"McCoy","year":"2013","journal-title":"Neuron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/00015555-0265","article-title":"Plasma neuropeptides and perception of pruritus in psoriasis","volume":"87","author":"Reich","year":"2007","journal-title":"Acta Derm. Venereol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2133.2011.10347.x","article-title":"Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch","volume":"165","author":"Taneda","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2133.1994.tb08502.x","article-title":"Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses","volume":"131","author":"Glinski","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-3-662-44605-8_17","article-title":"Neuraxial opioid-induced itch and its pharmacological antagonism","volume":"226","author":"Ko","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jdermsci.2008.08.011","article-title":"Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis","volume":"53","author":"Yamaguchi","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.2012.242","article-title":"NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin","volume":"133","author":"Rukwied","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","article-title":"Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells","volume":"184","author":"Niyonsaba","year":"2010","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-012-1293-6","article-title":"Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients","volume":"305","author":"Narbutt","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaci.2014.04.022","article-title":"Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis","volume":"134","author":"Volpe","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.4081\/dr.2019.8006","article-title":"Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris","volume":"11","author":"Suwarsa","year":"2019","journal-title":"Dermatol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/13813459508996127","article-title":"Interleukin-2 activates a sub-population of cutaneous C-fibre polymodal nociceptors in the rat hairy skin","volume":"103","author":"Martin","year":"1995","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_53","first-page":"415","article-title":"Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction","volume":"137","author":"Darsow","year":"1997","journal-title":"Br. J. Dermatol"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF00374079","article-title":"Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects","volume":"287","author":"Wahlgren","year":"1995","journal-title":"Arch. Dermatol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.03.004","article-title":"Participation of interleukin 17A in neuroimmune interactions","volume":"41","author":"Moynes","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Georgescu, S.R., Tampa, M., Caruntu, C., Sarbu, M.I., Mitran, C.I., Mitran, M.I., Matei, C., Constantin, C., and Neagu, M. (2019). Advances in Understanding the Immunological Pathways in Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030739"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.4049\/jimmunol.1600126","article-title":"Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway","volume":"198","author":"Lou","year":"2017","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","article-title":"The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch","volume":"138","author":"Nattkemper","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation","volume":"510","author":"Perro","year":"2014","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jid.2018.09.037","article-title":"Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis","volume":"139","author":"Itoh","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"17656","DOI":"10.1523\/JNEUROSCI.1090-13.2013","article-title":"A local source of FGF initiates development of the unmyelinated lineage of sensory neurons","volume":"33","author":"Hadjab","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0625.2006.00509.x","article-title":"Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis","volume":"16","author":"Kim","year":"2007","journal-title":"Exp. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fncel.2019.00422","article-title":"Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation","volume":"13","author":"Siiskonen","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/endo.139.1.5660","article-title":"Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects","volume":"139","author":"Theoharides","year":"1998","journal-title":"Endocrinology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.ajpath.2015.07.015","article-title":"Histamine released from epidermal keratinocytes plays a role in \u03b1-melanocyte-stimulating hormone-induced itching in mice","volume":"185","author":"Shimizu","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ajpath.2019.05.017","article-title":"Involvement of \u03b1-Melanocyte-Stimulating Hormone-Thromboxane A(2) System on Itching in Atopic Dermatitis","volume":"189","author":"Andoh","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jdermsci.2016.04.008","article-title":"Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice","volume":"83","author":"Wong","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/1346-8138.12248","article-title":"Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis","volume":"40","author":"Shimauchi","year":"2013","journal-title":"J. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1073\/pnas.72.12.5130","article-title":"Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2340\/0001555559505512","article-title":"Pruritus in polycythemia vera: Treatment with aspirin and possibility of platelet involvement","volume":"59","author":"Fjellner","year":"1979","journal-title":"Acta Derm. Venereol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2340\/00015555573743","article-title":"Pruritogenic activity of prostaglandin E2","volume":"57","author":"Strandberg","year":"1977","journal-title":"Acta Derm. Venereol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/all.13322","article-title":"The pruritogenic mediator endothelin-1 shifts the dendritic cell-T-cell response toward Th17\/Th1 polarization","volume":"73","author":"Nakahara","year":"2018","journal-title":"Allergy"},{"key":"ref_73","first-page":"839","article-title":"The neurogenic vasodilator response to endothelin-1: A study in human skin in vivo","volume":"85","author":"Katugampola","year":"2000","journal-title":"Exp. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1468-3083.2006.01869.x","article-title":"Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients","volume":"21","author":"Madej","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jdermsci.2017.03.005","article-title":"A possible role for CD26\/DPPIV enzyme activity in the regulation of psoriatic pruritus","volume":"86","author":"Komiya","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8171373","DOI":"10.1155\/2019\/8171373","article-title":"Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis","volume":"2019","author":"Aizawa","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm.3912","article-title":"STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch","volume":"21","author":"Koga","year":"2015","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuron.2012.09.014","article-title":"Neuropeptide transmission in brain circuits","volume":"76","year":"2012","journal-title":"Neuron"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-410X.2008.07493.x","article-title":"The concept of neurogenic inflammation","volume":"101","author":"Geppetti","year":"2008","journal-title":"BJU Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2133.2006.07518.x","article-title":"The role of neuropeptides in psoriasis","volume":"155","author":"Saraceno","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10241.x","article-title":"Expression of tachykinins and their receptors in plaque psoriasis with pruritus","volume":"164","author":"Amatya","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-biophys-051013-022826","article-title":"Itch mechanisms and circuits","volume":"43","author":"Han","year":"2014","journal-title":"Annu. Rev. Biophys."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2018.02.030","article-title":"Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial","volume":"78","author":"Yosipovitch","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e89362","DOI":"10.1172\/jci.insight.89362","article-title":"Dual action of neurokinin-1 antagonists on Mas-related GPCRs","volume":"1","author":"Azimi","year":"2016","journal-title":"JCI Insight"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2016.12.980","article-title":"Substance P activates Mas-related G protein-coupled receptors to induce itch","volume":"140","author":"Azimi","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0014-5793(78)81210-1","article-title":"Liver dipeptidyl aminopeptidase IV hydrolyzes substance P","volume":"91","author":"Heymann","year":"1978","journal-title":"FEBS Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.0503264102","article-title":"Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene","volume":"102","author":"Mogil","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1152\/physrev.00026.2005","article-title":"Neuronal control of skin function: The skin as a neuroimmunoendocrine organ","volume":"86","author":"Roosterman","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2340\/00015555-2704","article-title":"Involvement of \u00b5-opioid Receptors and \u03ba-opioid Receptors in Itch-related Scratching Behaviour of Imiquimod-induced Psoriasis-like Dermatitis in Mice","volume":"97","author":"Takahashi","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3182662098","article-title":"Endogenous opioid systems: Current concepts and clinical correlations","volume":"79","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2340\/00015555-2595","article-title":"Opioid Receptors in Psoriatic Skin: Relationship with Itch","volume":"97","author":"Kupczyk","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.alit.2016.10.003","article-title":"The molecular and cellular mechanisms of itch and the involvement of TRP channels in the peripheral sensory nervous system and skin","volume":"66","author":"Kittaka","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00281-015-0530-4","article-title":"Trp channels and itch","volume":"38","author":"Sun","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jid.2020.03.959","article-title":"Sensory Neuron-Expressed TRPC4 Is a Target for the Relief of Psoriasiform Itch and Skin Inflammation in Mice","volume":"140","author":"Lee","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0190-9622(93)70208-B","article-title":"A double-blind evaluation of topical capsaicin in pruritic psoriasis","volume":"29","author":"Ellis","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_96","first-page":"653","article-title":"Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro","volume":"6","author":"Angeletti","year":"1963","journal-title":"Dev. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1101\/gad.841400","article-title":"Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system","volume":"14","author":"Bibel","year":"2000","journal-title":"Genes Dev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2340\/00015555-2047","article-title":"Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis","volume":"95","author":"Roblin","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s004030050340","article-title":"Immunohistochemical study of epidermal nerve fibres in involved and uninvolved psoriatic skin using confocal laser scanning microscopy","volume":"290","author":"Pergolizzi","year":"1998","journal-title":"Arch. Dermatol. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1097\/j.pain.0000000000001025","article-title":"Role of neurturin in spontaneous itch and increased nonpeptidergic intraepidermal fiber density in a mouse model of psoriasis","volume":"158","author":"Sakai","year":"2017","journal-title":"Pain"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/exd.13947","article-title":"Itching for an answer: A review of potential mechanisms of scalp itch in psoriasis","volume":"28","author":"Leon","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1111\/bph.12823","article-title":"Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice","volume":"171","author":"Kasutani","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_104","first-page":"426","article-title":"Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations","volume":"32","author":"Adamski","year":"2015","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2019.01383","article-title":"Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases","volume":"10","author":"Gibbs","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e10697","DOI":"10.15252\/emmm.201910697","article-title":"Role of bulge epidermal stem cells and TSLP signaling in psoriasis","volume":"11","author":"Mellor","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archderm.1988.01670120027005","article-title":"Interleukin 2 and psoriasis","volume":"124","author":"Lee","year":"1988","journal-title":"Arch. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2340\/00015555-2801","article-title":"Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension","volume":"98","author":"Kimball","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaad.2016.07.034","article-title":"Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials","volume":"75","author":"Kimball","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ijd.13236","article-title":"Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: Results of two phase 3, randomized, placebo-controlled clinical trials","volume":"55","author":"Strober","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ruano, J., Su\u00e1rez-Fari\u00f1as, M., Shemer, A., Oliva, M., Guttman-Yassky, E., and Krueger, J.G. (2016). Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148450"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/jid.2013.166","article-title":"Overexpression of the gastrin-releasing peptide in cutaneous nerve fibers and its receptor in the spinal cord in primates with chronic itch","volume":"133","author":"Nattkemper","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41467-020-15230-y","article-title":"Exploration of sensory and spinal neurons expressing gastrin-releasing peptide in itch and pain related behaviors","volume":"11","author":"Barry","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Eberle, F.C., Br\u00fcck, J., Holstein, J., Hirahara, K., and Ghoreschi, K. (2016). Recent advances in understanding psoriasis. F1000Research, 5.","DOI":"10.12688\/f1000research.7927.1"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2016.08.008","article-title":"Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study","volume":"76","author":"Blauvelt","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cytogfr.2010.09.001","article-title":"Interleukin-26: An IL-10-related cytokine produced by Th17 cells","volume":"21","author":"Donnelly","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1359-6101(02)00012-6","article-title":"The family of IL-10-related cytokines and their receptors: Related, but to what extent?","volume":"13","author":"Kotenko","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/ni1474","article-title":"Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma","volume":"8","author":"Schoenborn","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/19420862.2019.1654305","article-title":"Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis","volume":"11","author":"Hatano","year":"2019","journal-title":"MAbs"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-008-0874-x","article-title":"Is there a role for mast cells in psoriasis?","volume":"300","author":"Harvima","year":"2008","journal-title":"Arch. Dermatol. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00403-010-1052-5","article-title":"GABA and GABA(A) receptor expression on immune cells in psoriasis: A pathophysiological role","volume":"302","author":"Nigam","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3389\/fimmu.2019.02847","article-title":"Emerging Topical and Systemic JAK Inhibitors in Dermatology","volume":"10","author":"Solimani","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ni.1701","article-title":"Selectivity and therapeutic inhibition of kinases: To be or not to be?","volume":"10","author":"Ghoreschi","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejcb.2011.07.006","article-title":"Signaling by IL-31 and functional consequences","volume":"91","author":"Cornelissen","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3389\/fimmu.2018.01595","article-title":"Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer","volume":"9","author":"Varricchi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 Family Cytokines IL-10 and IL-22: From Basic Science to Clinical Translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: From discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fimmu.2019.00204","article-title":"IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense","volume":"10","author":"Larochette","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bjd.12049","article-title":"STAT1 expression and activation is increased in lesional psoriatic skin","volume":"168","author":"Hald","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/exd.12128","article-title":"Studies of Jak\/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity","volume":"22","author":"Hald","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09546634.2013.861891","article-title":"The relationship between pruritus and the clinical signs of psoriasis in patients receiving tofacitinib","volume":"26","author":"Bushmakin","year":"2015","journal-title":"J. Dermatol. Treat."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/eci.12.1","article-title":"Stress, the neuroendocrine system and mast cells: Current understanding of their role in psoriasis","volume":"8","author":"Harvima","year":"2012","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/exd.14071","article-title":"Role of neuroimmune circuits and pruritus in psoriasis","volume":"29","author":"Ayasse","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/brbi.1998.0541","article-title":"Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders","volume":"13","author":"Singh","year":"1999","journal-title":"Brain Behav. Immun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2230.2009.03650.x","article-title":"Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells","volume":"35","author":"Shimoda","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.1998.tb09545.x","article-title":"Corticotropin-releasing hormone and inflammation","volume":"840","author":"Webster","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \u2018brain-skin connection\u2019","volume":"27","author":"Paus","year":"2006","journal-title":"Trends Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.2016.1153064","article-title":"Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis","volume":"25","author":"Malecic","year":"2016","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1346-8138.14033","article-title":"Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and S\u00e9zary syndrome","volume":"45","author":"Sakamoto","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_142","first-page":"393","article-title":"Prostaglandin endoperoxide synthase: Why two isoforms?","volume":"270","author":"Williams","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Carstens, E., and Akiyama, T. (2014). Frontiers in Neuroscience Lipid Mediators and Itch. Itch: Mechanisms and Treatment, CRC Press\/Taylor & Francis LLC.","DOI":"10.1201\/b16573"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(98)00440-3","article-title":"Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice","volume":"353","author":"Andoh","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2004.10.031","article-title":"Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC\/Nga mice with atopic dermatitis","volume":"505","author":"Arai","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1038\/s41598-020-66490-z","article-title":"Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation","volume":"10","author":"Nakahara","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_147","first-page":"1146","article-title":"Endothelin-1 causes pruritus in mice","volume":"231","author":"Trentin","year":"2006","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.bjp.0707216","article-title":"Endothelin-1 activates ETA receptors to cause reflex scratching in BALB\/c mice","volume":"151","author":"McQueen","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3389\/fimmu.2017.01878","article-title":"E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy","volume":"8","author":"Silva","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_151","first-page":"85","article-title":"Nerve growth factor and keratinocytes: A role in psoriasis","volume":"10","author":"Pincelli","year":"2000","journal-title":"Eur. J. Dermatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"Morimoto","year":"1998","journal-title":"Immunol. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.2741\/4671","article-title":"A novel role for CD26\/dipeptidyl peptidase IV as a therapeutic target","volume":"23","author":"Ohnuma","year":"2018","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-385855-9.00003-5","article-title":"Dipeptidyl peptidase in autoimmune pathophysiology","volume":"53","author":"Ohnuma","year":"2011","journal-title":"Adv. Clin. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1182\/blood.V83.3.799.799","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils","volume":"83","author":"Kjeldsen","year":"1994","journal-title":"Blood"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","article-title":"Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation","volume":"37","author":"Xiao","year":"2017","journal-title":"Annu. Rev. Nutr."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaad.2020.01.056","article-title":"Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial","volume":"82","author":"Pariser","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"adv00027","DOI":"10.2340\/00015555-3347","article-title":"A New Generation of Treatments for Itch","volume":"100","author":"Fowler","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-017-0709-1","article-title":"Apremilast: A Review in Psoriasis and Psoriatic Arthritis","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2340\/00015555-3195","article-title":"Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials","volume":"99","author":"Yosipovitch","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaad.2016.07.040","article-title":"Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis","volume":"75","author":"Feldman","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.aller.2013.07.011","article-title":"Regulation of human skin mast cell histamine release by PDE inhibitors","volume":"43","author":"Eskandari","year":"2015","journal-title":"Allergol. Immunopathol. (Madr.)"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/exd.12377","article-title":"Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis","volume":"23","author":"Andoh","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/exd.12606","article-title":"A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves","volume":"24","author":"Wakita","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2340\/00015555-3086","article-title":"Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis","volume":"99","author":"Hashimoto","year":"2019","journal-title":"Acta Derm. Venereol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/8406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:31:16Z","timestamp":1760178676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/8406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":168,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["ijms21218406"],"URL":"https:\/\/doi.org\/10.3390\/ijms21218406","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]}}}